Opus Genetics (IRD) Other Non Operating Income (2010 - 2026)
Opus Genetics' (IRD) quarterly Other Non Operating Income came in at $844000.0 in Q1 2026, up 179.47% year-on-year from $302000.0 in Q1 2025, and down 87.31% on a QoQ basis from $6.7 million in Q4 2025.
Opus Genetics (IRD) Other Non Operating Income (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has 12 years of Other Non Operating Income data on file, last reported at $844000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 179.47% year-over-year to $844000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 121.18% decrease from a year earlier, with the FY2025 full-year figure at $848000.0, down 81.03% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $844000.0, down from $6.7 million in the prior quarter.
- Over the last five years, Other Non Operating Income for IRD reached as high as $6.7 million in Q4 2025 and fell as low as -$9.5 million in Q3 2025.
- Historically, Other Non Operating Income has averaged $344923.1 across 5 years, with a median of $428000.0 in 2023.
- Across the five-year window, Other Non Operating Income surged 23426.32% in 2024 and sank 2072.05% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$15000.0 in 2022, then jumped by 226.67% to $19000.0 in 2023, then jumped by 23426.32% to $4.5 million in 2024, then soared by 48.79% to $6.7 million in 2025, then slumped by 87.31% to $844000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $844000.0 in Q1 2026, $6.7 million in Q4 2025, and -$9.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 844,000.00 |
| Dec 31, 2025 | 6.65 Mn |
| Sep 30, 2025 | -9.53 Mn |
| Jun 30, 2025 | 917,000.00 |
| Mar 31, 2025 | 302,000.00 |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 483,000.00 |
| Mar 31, 2024 | 602,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | -707,000.00 |
| Jun 30, 2023 | 428,000.00 |
| Dec 31, 2022 | -15,000.00 |
| Jun 30, 2022 | 15,000.00 |
| Dec 31, 2021 | -33.83 Mn |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | -33.83 Mn |
| Dec 31, 2020 | -1.50 Mn |
| Jun 30, 2020 | -919,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Sep 30, 2018 | -710,065.00 |